Clinical Trials
4 trialsNCT05755269 2026-05-01
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Terminated
NCT06534424 2025-06-27
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT05876728 2023-05-25
Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer
Sohag University
Unknown
NCT00580021 2016-01-28
Clinical Outcomes in Hereditary Cancer
Memorial Sloan Kettering Cancer Center
Withdrawn